Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Innovation et propriété intellectuelle · 24/02/20231 min de lecture
Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments
Traduction automatique locale · Langue originale de la source
Résumé
The United States Patent and Trademark Office (USPTO), Department of Commerce, in collaboration with the United States Food and Drug Administration (FDA), Department of Health and Human Services, is extending the written comment period for the notice titled "Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments" that was published in the Federal Register on November 7, 2022, until March 10, 2023.
Langue originale de la source: Federal Register — Patent and Trademark OfficeOuvrir le communiqué original →